194 related articles for article (PubMed ID: 1702309)
1. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients.
Falini B; Pileri SA; Flenghi L; Liberati M; Stein H; Gerli R; Minelli O; Martelli MF; Lauria F; Poggi S
Br J Haematol; 1990 Dec; 76(4):460-8. PubMed ID: 1702309
[TBL] [Abstract][Full Text] [Related]
2. LF61: a new monoclonal antibody directed against a trimeric molecule (150 kDa, 125 kDa, 105 kDa) associated with hairy cell leukaemia.
Flenghi L; Spinozzi F; Stein H; Krushwitz M; Pileri S; Falini B
Br J Haematol; 1990 Dec; 76(4):451-9. PubMed ID: 2265107
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic relevance of peripheral blood immunocytochemistry in hairy cell leukaemia.
Cordone I; Annino L; Masi S; Pescarmona E; Rahimi S; Ferrari A; Giubilei E; Pignoloni P; Faraggiana T; Mandelli F
J Clin Pathol; 1995 Oct; 48(10):955-60. PubMed ID: 8537498
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique.
Vardiman JW; Gilewski TA; Ratain MJ; Bitter MA; Bradlow BA; Golomb HM
Am J Clin Pathol; 1988 Sep; 90(3):250-6. PubMed ID: 2458031
[TBL] [Abstract][Full Text] [Related]
5. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H
Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia.
Thaler J; Dietze O; Faber V; Greil R; Gastl G; Denz H; Ho AD; Huber H
Leukemia; 1990 Mar; 4(3):170-6. PubMed ID: 2314116
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow and splenic histology in hairy cell leukaemia.
Wotherspoon A; Attygalle A; Mendes LS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
9. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.
Hakimian D; Tallman MS; Kiley C; Peterson L
Blood; 1993 Sep; 82(6):1798-802. PubMed ID: 7691237
[TBL] [Abstract][Full Text] [Related]
10. Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukaemia. An immunocytochemical study of 36 cases.
Falini B; Pulford K; Erber WN; Posnett DN; Pallesen G; Schwarting R; Annino L; Cafolla A; Canino S; Mori A
Histopathology; 1986 Jul; 10(7):671-87. PubMed ID: 3462119
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
[TBL] [Abstract][Full Text] [Related]
12. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells.
Mulligan SP; Travade P; Matutes E; Dearden C; Visser L; Poppema S; Catovsky D
Blood; 1990 Sep; 76(5):959-64. PubMed ID: 2118401
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype of hairy-cell leukaemia after cold polymerization of methyl-methacrylate embeddings from 50 diagnostic bone marrow biopsies.
Kreft A; Büsche G; Bernhards J; Georgii A
Histopathology; 1997 Feb; 30(2):145-51. PubMed ID: 9067739
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ
Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460
[TBL] [Abstract][Full Text] [Related]
15. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
16. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
17. Ber-ACT8: new monoclonal antibody to the mucosa lymphocyte antigen.
Kruschwitz M; Fritzsche G; Schwarting R; Micklem K; Mason DY; Falini B; Stein H
J Clin Pathol; 1991 Aug; 44(8):636-45. PubMed ID: 1890196
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.
Robbins BA; Ellison DJ; Spinosa JC; Carey CA; Lukes RJ; Poppema S; Saven A; Piro LD
Blood; 1993 Aug; 82(4):1277-87. PubMed ID: 7688993
[TBL] [Abstract][Full Text] [Related]
20. Antigenic phenotypes of hairy cell leukemia and monocytoid B-cell lymphoma: an immunohistochemical evaluation of 66 cases.
Stroup R; Sheibani K
Hum Pathol; 1992 Feb; 23(2):172-7. PubMed ID: 1740301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
